First worldwide use of the hybrid system for extracorporeal circulation in heart transplant.
Cardiac surgery
Gas micro-emboli
Heart transplant
Hybrid system
Inflammatory response
Journal
Journal of cardiothoracic surgery
ISSN: 1749-8090
Titre abrégé: J Cardiothorac Surg
Pays: England
ID NLM: 101265113
Informations de publication
Date de publication:
27 Aug 2024
27 Aug 2024
Historique:
received:
19
06
2024
accepted:
13
08
2024
medline:
28
8
2024
pubmed:
28
8
2024
entrez:
27
8
2024
Statut:
epublish
Résumé
This case report documents the first worldwide use of the Hybrid System from Spectrum Medical in a heart transplant procedure, focusing on its safety and efficacy. Traditional cardiopulmonary bypass systems often use an open reservoir, which increases the blood's exposure to air, thereby heightening the risk of an inflammatory response and gas embolism. In contrast, the Hybrid System is designed to improve surgical outcomes by significantly reducing the blood-air interface. This system utilizes a dual-chamber cardiotomy-venous reservoir with a collapsible soft bag, effectively minimizing blood contact with air and foreign materials. However, it is important to note that there is currently no evidence supporting the use of this methodology specifically in heart transplants. A 41-year-old male managed with a left ventricular assist device because of dilated cardiomyopathy underwent a heart transplant using the Hybrid System. The perioperative and postoperative data provided evidence of the system's effectiveness. The selection of this patient was due to the absence of significant comorbidities unrelated to his primary cardiac condition, making him an ideal candidate to evaluate the system's performance. The Hybrid System is safe and efficient. The successful implementation in this case highlights its advantages over traditional cardiopulmonary bypass systems, suggesting a promising future in cardiac surgery. Further studies with routine cardiac surgery patients are required to validate these findings.
Sections du résumé
BACKGROUND
BACKGROUND
This case report documents the first worldwide use of the Hybrid System from Spectrum Medical in a heart transplant procedure, focusing on its safety and efficacy. Traditional cardiopulmonary bypass systems often use an open reservoir, which increases the blood's exposure to air, thereby heightening the risk of an inflammatory response and gas embolism. In contrast, the Hybrid System is designed to improve surgical outcomes by significantly reducing the blood-air interface. This system utilizes a dual-chamber cardiotomy-venous reservoir with a collapsible soft bag, effectively minimizing blood contact with air and foreign materials. However, it is important to note that there is currently no evidence supporting the use of this methodology specifically in heart transplants.
CASE PRESENTATION
METHODS
A 41-year-old male managed with a left ventricular assist device because of dilated cardiomyopathy underwent a heart transplant using the Hybrid System. The perioperative and postoperative data provided evidence of the system's effectiveness. The selection of this patient was due to the absence of significant comorbidities unrelated to his primary cardiac condition, making him an ideal candidate to evaluate the system's performance.
CONCLUSION
CONCLUSIONS
The Hybrid System is safe and efficient. The successful implementation in this case highlights its advantages over traditional cardiopulmonary bypass systems, suggesting a promising future in cardiac surgery. Further studies with routine cardiac surgery patients are required to validate these findings.
Identifiants
pubmed: 39192346
doi: 10.1186/s13019-024-03010-4
pii: 10.1186/s13019-024-03010-4
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
495Informations de copyright
© 2024. The Author(s).
Références
Velho TR, Pereira RM, Guerra NC, Ferreira R, Pedroso D, Neves-Costa A, Nobre Â, Moita LF. The impact of cardiopulmonary bypass time on the sequential organ failure Assessment score after cardiac surgery. Interdiscip Cardiovasc Thorac Surg. 2024;38(5). https://doi.org/10.1093/icvts/ivae082 .
Condello I, Santarpino G, Nasso G, Fiore F, Moscarelli M, Mastroroberto P, Speziale G. Air, inflammation and biocompatibility of the extracorporeal circuits. Perfusion. 2021;36(8):781–5. https://doi.org/10.1177/0267659120968364 .
doi: 10.1177/0267659120968364
pubmed: 33112217
Sibel Aydin D, Cekmecelioglu S, Celik I, Yerli. Kaan Kirali the effect of vacuum-assisted venous drainage on hemolysis during cardiopulmonary bypass. Am J Cardiovasc Dis. 2020;10(4):473–8. PMID: 33224598.
pubmed: 33224598
pmcid: 7675161
Stehouwer MC, de Vroege R, Bruggemans EF, Hofman FN, Molenaar MA, van OeverenW BA, Bruins P. The influence of gaseous microemboli on various biomarkers after minimized cardiopulmonary bypass. Perfusion. 2020;35(3):202–8. https://doi.org/10.1177/0267659119867572 .
doi: 10.1177/0267659119867572
pubmed: 31402782
Bauer A, Hausmann H, Schaarschmidt J, et al. Is 300 seconds ACT safe and efficient during MiECC procedures? Thorac Cardiovasc Surg. 2019;67(3):191–202. https://doi.org/10.1055/s-0037-1609019 .
doi: 10.1055/s-0037-1609019
pubmed: 29290078
Elwatidy A, et al. Comparison of miniaturized and conventional cardiopulmonary bypass circuits regarding inflammatory response and clinical outcomes: a systematic review and meta-analysis. Perfusion. 2020;35(4):323–33.
Murphy GJ, et al. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007;116(22):2544–52.
doi: 10.1161/CIRCULATIONAHA.107.698977
pubmed: 17998460
Karkouti K, et al. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation. 2009;119(4):495–502.
doi: 10.1161/CIRCULATIONAHA.108.786913
pubmed: 19153273
Cardiopulmonary Bypass Advances in Extracorporeal Life Support, 1st Edition - November 30, 2022, Editors: Kaan Kırali, Joseph S, Coselli. Afksendiyos Kalangos, Paperback ISBN: 9780443189180.
Eisenberg MS, Chen HJ, Warshofsky MK, et al. Elevated levels of plasma C-reactive protein are associated with decreased graft survival in cardiac transplant recipients. Circulation. 2000;102(17):2100–4. https://doi.org/10.1161/01.cir.102.17.2100 .
doi: 10.1161/01.cir.102.17.2100
pubmed: 11044427
Chotimol P, Lansdowne W, Machin D, Binas K, Angelini GD, Gibbison B. Hypobaric type oxygenators – physics and physiology. Perfusion. 2024;0(0). https://doi.org/10.1177/02676591241232824 .
Castell JV, Gómez-Lechón MJ, David M, et al. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett. 1989;242(2):237–9. https://doi.org/10.1016/0014-5793(89)80476-4 .
doi: 10.1016/0014-5793(89)80476-4
pubmed: 2464504